Blackwell, J;
Saxena, S;
Jayasooriya, N;
Petersen, I;
Hotopf, M;
Creese, H;
Bottle, A;
... POP-IBD Study Group, .; + view all
(2022)
Stoma Formation in Crohn's Disease and the Likelihood of Antidepressant Use: A Population-Based Cohort Study.
Clinical Gastroenterology and Hepatology
, 20
(4)
e703-e710.
10.1016/j.cgh.2020.12.026.
Preview |
Text (Accepted Manuscript)
Petersen_Stoma formation and antidepressant use - Unmarked Copy.pdf - Accepted Version Download (395kB) | Preview |
Preview |
Text (Supplementary Information)
Petersen_What you need to know.pdf - Accepted Version Download (75kB) | Preview |
![[thumbnail of Figure 1]](https://discovery.ucl.ac.uk/10141874/5/Figure%201.jpg)  Preview |
Image (Figure 1)
Figure 1.jpg - Accepted Version Download (65kB) | Preview |
![[thumbnail of Figure 2]](https://discovery.ucl.ac.uk/10141874/10/Figure%202.jpg)  Preview |
Image (Figure 2)
Figure 2.jpg - Accepted Version Download (66kB) | Preview |
Abstract
BACKGROUND & AIMS: The impact of a temporary or permanent stoma on mental health in Crohn's Disease (CD) is unknown. The aim was to examine the association between intestinal surgery and stoma formation and subsequent antidepressant medication (ADM) use. METHODS: Using the Clinical Practice Research Datalink, we identified individuals with CD who underwent intestinal surgery between 1998-2018. We excluded individuals with a prescription for an ADM in the 6 months before surgery. Individuals were stratified into three groups: no stoma, temporary stoma, and permanent stoma. We used Kaplan-Meier curves to examine initiation of ADM after intestinal surgery and Cox regression to identify risk factors for ADM use after intestinal surgery. RESULTS: We identified 1,272 cases of CD undergoing their first intestinal surgery. Of these, 871 (68.5%) had no stoma, 191 (15.0%) had a temporary stoma and 210 (16.5%) had a permanent stoma. The 10-year cumulative incidence of ADM use was 26.4%, 33.4% and 37.3% respectively. Individuals with a permanent stoma were 71% more likely to receive an ADM than those with no stoma (HR 1.71, 95% CI 1.20-2.44). Individuals with a temporary stoma reversed within 12 months had a similar likelihood of ADM use to those without stoma formation (HR 0.99, 95% CI 0.64-1.53) whereas temporary stoma formation with late reversal after 12 months was associated with significantly greater likelihood of ADM use (HR 1.85, 95% CI 1.15-2.96). CONCLUSIONS: Permanent stomas and temporary stomas with late reversal surgery are associated with increased ADM use after intestinal surgery, likely associated with increased anxiety and depression.
| Type: | Article |
|---|---|
| Title: | Stoma Formation in Crohn's Disease and the Likelihood of Antidepressant Use: A Population-Based Cohort Study |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.cgh.2020.12.026 |
| Publisher version: | https://doi.org/10.1016/j.cgh.2020.12.026 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| Keywords: | Antidepressants, Crohn's Disease, Psychosomatic Medicine, Stoma |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Primary Care and Population Health |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10141874 |
Archive Staff Only
 |
View Item |
